Kim Young Seok
Department of Internal Medicine, Bucheon Hospital, Soon Chun Hyang University College of Medicine, Bucheon, Korea.
Korean J Gastroenterol. 2010 Sep;56(3):168-85. doi: 10.4166/kjg.2010.56.3.168.
Ascites, hepatic encephalopathy and variceal hemorrhage are three major complications of portal hypertension. The diagnostic evaluation of ascites involves an assessment of its etiology by determining the serum-ascites albumin gradient and the exclusion of spontaneous bacterial peritonitis. Ascites is primarily related to an inability to excrete an adequate amount of sodium into urine, leading to a positive sodium balance. Sodium restriction and diuretic therapy are keys of ascites control. But, with the case of refractory ascites, large volume paracentesis and transjugular portosystemic shunts are required. In hepatorenal syndrome, splanchnic vasodilatation with reduction in effective arterial volume causes intense renal vasoconstriction. Splanchnic and/or peripheral vasoconstrictors with albumin infusion, and renal replacement therapy are only bridging therapy. Liver transplantation is the only definitive modality of improving the long term prognosis.
腹水、肝性脑病和静脉曲张出血是门静脉高压的三大主要并发症。腹水的诊断评估包括通过测定血清腹水白蛋白梯度评估其病因,并排除自发性细菌性腹膜炎。腹水主要与无法将足够量的钠排泄到尿液中有关,导致钠平衡为正。限制钠摄入和利尿剂治疗是控制腹水的关键。但是,对于难治性腹水,需要进行大量腹腔穿刺放液和经颈静脉肝内门体分流术。在肝肾综合征中,内脏血管扩张伴有效动脉血容量减少会导致强烈的肾血管收缩。使用白蛋白输注的内脏和/或外周血管收缩剂以及肾脏替代治疗只是过渡性治疗。肝移植是改善长期预后的唯一确定性方法。